1. Centers for disease control and prevention (CDC). Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep. 2008;57(1):1-5.
2. Practice Bulletin No. 163: screening for fetal aneuploidy.Obstet Gynecol. 2016;127(5):e123-e137. doi:10.1097/AOG.0000000000001406
3. Practice Bulletin No. 162: prenatal diagnostic testing for genetic disorders. Obstet Gynecol. 2016;127(5):e108-e122. doi:10.1097/AOG. 0000000000001405
4. Committee Opinion No. 640: cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015;126(3):e31-e37. doi:10.1097/AOG. 0000000000001051
5. Bianchi DW. Fetology?: diagnosis and management of the fetal patient. 2nd ed. McGraw-Hill Medical. 2010.
6. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2015;45(3):249-266. doi:10.1002/uog.14791
7. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109(1):217-227. doi:10.1097/00006250-200701000-00054
8. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992;304(6831):867-869. doi:10.1136/bmj. 304.6831.867
9. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome.N Engl J Med. 2005; 353(19):2001-2011. doi:10.1056/NEJMoa043693
10. Conde-Agudelo A, Kafury-Goeta AC. Triple-marker test as screening for Down syndrome: a meta-analysis. Obstet Gynecol Surv. 1998;53(6): 369-376. doi:10.1097/00006254-199806000-00022
11. Vayna AM, Veduta A, Duta S, et al. Diagnosis of fetal structural anomalies at 11 to 14 weeks. J Ultrasound Med. 2018;37(8):2063-2073. doi:10.1002/jum.14561
12. Paladini D, Volpe P. Ultrasound of congenital fetal anomalies: differential diagnosis and prognostic indicators. CRC press. 2018.
13. Salomon LJ, Alfirevic Z, Berghella V, et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan.Ultrasound Obstet Gynecol. 2011;37(1):116-126. doi:10.1002/uog.8831
14. Colby CE, Carey WA, Blumenfeld YJ, Hintz SR. Infants with prenatally diagnosed anomalies: special approaches to preparation and resuscitation. Clin Perinatol. 2012;39(4):871-887. doi:10.1016/j.clp.2012.09.012
15. Wataganara T, Grunebaum A, Chervenak F, Wielgos M. Delivery modes in case of fetal malformations. J Perinat Med. 2017;45(3):273-279. doi:10.1515/jpm-2015-0364
16. Douglas Wilson R, Van Mieghem T, Langlois S, Church P. Guideline No. 410: prevention, screening, diagnosis, and pregnancy management for fetal neural tube defects. J Obstet Gynaecol Can. 2021;43(1):124-139.e8. doi:10.1016/j.jogc.2020.11.003
17. Sanapo L, Moon-Grady AJ, Donofrio MT. Perinatal and delivery management of infants with congenital heart disease. Clin Perinatol. 2016;43(1):55-71. doi:10.1016/j.clp.2015.11.004
18. Bielicki IN, Somme S, Frongia G, Holland-Cunz SG, Vuille-Dit-Bille RN. Abdominal wall defects-current treatments. Children (Basel). 2021; 8(2):170. doi:10.3390/children8020170
19. Segel SY, Marder SJ, Parry S, Macones GA. Fetal abdominal wall defects and mode of delivery: a systematic review. Obstet Gynecol. 2001;98(5 Pt 1):867-873. doi:10.1016/s0029-7844(01)01571-x
20. Kashyap A, DeKoninck P, Crossley K, et al. Antenatal medical therapies to improve lung development in congenital diaphragmatic hernia.Am J Perinatol. 2018;35(9):823-836. doi:10.1055/s-0037-1618603
21. Bradshaw CJ, Thakkar H, Knutzen L, et al. Accuracy of prenatal detection of tracheoesophageal fistula and oesophageal atresia. J Pediatr Surg. 2016;51(8):1268-1272. doi:10.1016/j.jpedsurg.2016.02.001
22. D’Eufemia MD, Cianci S, Di Meglio F, et al. Congenital high airway obstruction syndrome (CHAOS): discussing the role and limits of prenatal diagnosis starting from a single-center case series. J Prenat Med. 2016;10(1-2):4-7. doi:10.11138/jpm/2016.10.1.004
23. Okada T, Sasaki F, Cho K, et al. Management and outcome in prenatally diagnosed sacrococcygeal teratomas. Pediatr Int. 2008;50(4):576-580. doi:10.1111/j.1442-200X.2008.02703.x
24. Sinha A, Bagga A, Krishna A, et al. Revised guidelines on management of antenatal hydronephrosis. Indian J Nephrol. 2013;23(2):83-97. doi:10. 4103/0971-4065.109403
25. Society for Maternal-Fetal Medicine (SMFM). Electronic address:
[email protected], Norton ME, Cheng Y, et al. SMFM fetal anomalies consult series #4: genitourinary anomalies. Am J Obstet Gynecol. 2021; 225(5):B2-B35. doi:10.1016/j.ajog.2021.06.009
26. García-Díaz L, Chimenea A, de Agustín JC, Pavón A, Antiñolo G. Ex-utero intrapartum treatment (EXIT): indications and outcome in fetal cervical and oropharyngeal masses. BMC Pregnancy Childbirth. 2020; 20(1):598. doi:10.1186/s12884-020-03304-0
27. Dingemann C, Eaton S, Aksnes G, et al. ERNICA consensus conference on the management of patients with esophageal atresia and tracheoesophageal fistula: follow-up and framework. Eur J Pediatr Surg. 2020;30(6):475-482. doi:10.1055/s-0039-3400284
28. David M, Lamas-Pinheiro R, Henriques-Coelho T. Prenatal and postnatal management of congenital pulmonary airway malformation. Neonatology. 2016;110(2):101-115. doi:10.1159/000440894
29. Luks FI, Johnson A, Polzin WJ; North American Fetal Therapy Network. Innovation in maternal-fetal therapy: a position statement from the North American Fetal Therapy Network. Obstet Gynecol. 2015;125(3):649-652. doi:10.1097/AOG.0000000000000689
30. MacKenzie TC. Fetal Surgical conditions and the unraveling of maternal-fetal tolerance. J Pediatr Surg. 2016;51(2):197-199. doi:10.1016/ j.jpedsurg.2015.10.059